Log In
Print this Print this

Captisol-enabled lamotrigine

  Manage Alerts
Collapse Summary General Information
Company Ligand Pharmaceuticals Inc.
DescriptionCaptisol-enabled sodium channel inhibitor
Molecular Target Sodium channel
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationSeizures
Indication DetailsTreat hospital-based seizures
Regulatory Designation
PartnerCURx Pharmaceuticals Inc.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today